Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 2/2011

Sonderheft 2/2011

IX Madrid Breast Cancer Conference

Inhaltsverzeichnis ( 27 Artikel )

01.12.2011 | Oral presentation | Sonderheft 2/2011

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Molecular classification of triple-negative tumors

01.12.2011 | Oral presentation | Sonderheft 2/2011

Poly(ADP-ribose) polymerase inhibitor development: are we in the right direction?

01.12.2011 | Oral presentation | Sonderheft 2/2011

Epithelial-mesenchymal transition as a mechanism for the progression of breast carcinoma

01.12.2011 | Oral presentation | Sonderheft 2/2011

Epigenetics of breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Immunity and autoimmunity in breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Insulin resistance in breast cancer: relevance and clinical implications

01.12.2011 | Oral presentation | Sonderheft 2/2011

The phosphatidylinositol-3 kinase/mTOR pathway: new agents

01.12.2011 | Oral presentation | Sonderheft 2/2011

DNA repair and breast cancer: therapeutic opportunities

01.12.2011 | Oral presentation | Sonderheft 2/2011

NoncodingRNAs: from bench to bedside

01.12.2011 | Oral presentation | Sonderheft 2/2011

Targeting HER2 in breast cancer: beyond trastuzumab

01.12.2011 | Oral presentation | Sonderheft 2/2011

Design of RESILIENCE: a phase 3 trial comparing capecitabine in combination with sorafenib or placebo for treatment of locally advanced or metastatic HER2-negative breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Molecular heterogeneity of luminal breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Translational breast cancer research in luminal breast cancer

01.12.2011 | Oral presentation | Sonderheft 2/2011

Interpretation and molecular validation of biomarker studies

01.12.2011 | Poster presentation | Sonderheft 2/2011

Clinical features and prognosis of tubular breast cancer

01.12.2011 | Poster presentation | Sonderheft 2/2011

Abstract withdrawn

01.12.2011 | Poster presentation | Sonderheft 2/2011

Nestin and collagen triple helix repeat containing 1 in breast cancer progression

01.12.2011 | Poster presentation | Sonderheft 2/2011

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy

01.12.2011 | Poster presentation | Sonderheft 2/2011

Oestrogen receptor status predicts for local recurrence following wide local excision for breast tumours

01.12.2011 | Poster presentation | Sonderheft 2/2011

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value

01.12.2011 | Poster presentation | Sonderheft 2/2011

Lobular carcinoma of the breast: outcome of 205 patients

01.12.2011 | Poster presentation | Sonderheft 2/2011

BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients

01.12.2011 | Poster presentation | Sonderheft 2/2011

Role of CCND1 and C-MYC oncogenes in metastatic breast cancer patients treated by herceptin

01.12.2011 | Poster presentation | Sonderheft 2/2011

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples

01.12.2011 | Poster presentation | Sonderheft 2/2011

Quantitative proteomics reveals novel proteins and central pathways associated with endocrine resistance in breast cancer

01.12.2011 | Poster presentation | Sonderheft 2/2011

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise